锦好医疗(872925)
 
 
  日线
顶尖财经网欢迎您!
  K线
 
 最新动态
  投资评级

研究机构 评级日期 最新评级 上次评级
暂无数据
  盈利预测
  财务数据
    截至第三季度实现净利润0.20亿元,每股收益0.20元。

    截至第三季度最新股东权益37157.00万元,未分配利润9511.31万元。

    截至第三季度最新总资产42145.71万元,负债4988.72万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入141,067,004.29100,799,557.5559,366,785.38195,132,408.42
营业总成本122,022,382.3284,890,904.1146,295,220.78153,591,754.82
营业利润21,112,089.0517,459,261.1513,246,343.8641,865,158.36
利润总额20,722,378.8717,391,026.1913,258,282.842,346,262.94
净利润19,790,768.2915,934,474.2712,005,443.6339,958,902.28
其他综合收益225,887.62225,887.62--
综合收益总额20,016,655.9116,160,361.8912,005,443.6339,958,902.28
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计164,067,772.15166,064,663.87190,398,047.64186,990,897.19
非流动资产合计257,389,345.03258,087,713.69259,504,061.89230,673,684.25
资产总计421,457,117.18424,152,377.56449,902,109.53417,664,581.44
流动负债合计44,678,656.2850,429,583.7272,255,980.8347,506,643.47
非流动负债合计5,208,493.935,375,911.655,755,415.155,398,395.81
负债合计49,887,150.2155,805,495.3778,011,395.9852,905,039.28
归属于母公司股东权益合计372,328,497.59368,441,996.53372,237,089.22365,896,050.23
股东权益合计371,569,966.97368,346,882.19371,890,713.55364,759,542.16
负债和股东权益合计421,457,117.18424,152,377.56449,902,109.53417,664,581.44
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计169,813,382.67127,395,951.8254,310,200.09200,327,213.07
经营活动现金流出小计141,437,046.32104,487,352.2348,228,682.4172,964,848.96
经营活动产生的现金流量净额28,376,336.3522,908,599.596,081,517.6927,362,364.11
投资活动现金流入小计276,917,883.53207,375,725.98105,611,289.58461,283,940.92
投资活动现金流出小计271,016,096.91192,601,265.7392,048,941.13524,452,611.95
投资活动产生的现金流量净额5,901,786.6214,774,460.2513,562,348.45-63,168,671.03
筹资活动现金流入小计3,380,000--7,627,500
筹资活动现金流出小计11,113,293.689,900,408.15426,295.9824,070,521.32
筹资活动产生的现金流量净额-7,733,293.68-9,900,408.15-426,295.98-16,443,021.32
汇率变动对现金及现金等价物的影响148,491.74605,253.05-340,435.782,741,550.01
现金及现金等价物净增加额26,693,321.0328,387,904.7418,877,134.38-49,507,778.23
期末现金及现金等价物余额48,825,825.9550,611,527.8441,002,737.7722,132,504.92
  主营收入+营业利润
 
  净利润+每股收益
  股东权益+未分配利润
 
  总资产+负债
  投资要点

    截至第三季度实现净利润0.20亿元,每股收益0.20元。

    截至第三季度最新股东权益37157.00万元,未分配利润9511.31万元。

    截至第三季度最新总资产42145.71万元,负债4988.72万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入141,067,004.29100,799,557.5559,366,785.38195,132,408.42
营业总成本122,022,382.3284,890,904.1146,295,220.78153,591,754.82
营业利润21,112,089.0517,459,261.1513,246,343.8641,865,158.36
利润总额20,722,378.8717,391,026.1913,258,282.842,346,262.94
净利润19,790,768.2915,934,474.2712,005,443.6339,958,902.28
其他综合收益225,887.62225,887.62--
综合收益总额20,016,655.9116,160,361.8912,005,443.6339,958,902.28
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计164,067,772.15166,064,663.87190,398,047.64186,990,897.19
非流动资产合计257,389,345.03258,087,713.69259,504,061.89230,673,684.25
资产总计421,457,117.18424,152,377.56449,902,109.53417,664,581.44
流动负债合计44,678,656.2850,429,583.7272,255,980.8347,506,643.47
非流动负债合计5,208,493.935,375,911.655,755,415.155,398,395.81
负债合计49,887,150.2155,805,495.3778,011,395.9852,905,039.28
归属于母公司股东权益合计372,328,497.59368,441,996.53372,237,089.22365,896,050.23
股东权益合计371,569,966.97368,346,882.19371,890,713.55364,759,542.16
负债和股东权益合计421,457,117.18424,152,377.56449,902,109.53417,664,581.44
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计169,813,382.67127,395,951.8254,310,200.09200,327,213.07
经营活动现金流出小计141,437,046.32104,487,352.2348,228,682.4172,964,848.96
经营活动产生的现金流量净额28,376,336.3522,908,599.596,081,517.6927,362,364.11
投资活动现金流入小计276,917,883.53207,375,725.98105,611,289.58461,283,940.92
投资活动现金流出小计271,016,096.91192,601,265.7392,048,941.13524,452,611.95
投资活动产生的现金流量净额5,901,786.6214,774,460.2513,562,348.45-63,168,671.03
筹资活动现金流入小计3,380,000--7,627,500
筹资活动现金流出小计11,113,293.689,900,408.15426,295.9824,070,521.32
筹资活动产生的现金流量净额-7,733,293.68-9,900,408.15-426,295.98-16,443,021.32
汇率变动对现金及现金等价物的影响148,491.74605,253.05-340,435.782,741,550.01
现金及现金等价物净增加额26,693,321.0328,387,904.7418,877,134.38-49,507,778.23
期末现金及现金等价物余额48,825,825.9550,611,527.8441,002,737.7722,132,504.92
  十大流通股东
十大流通股东 报告期:2023-09-30
股东名称 持股数量(万股) 占总股本比例(%) 上期持股变化(万股)
王敏635.1511.490.00
博尔乐远东有限公司504.009.110.00
王芳476.348.610.00
惠州市锦同声投资合伙企业(有限合伙)278.385.030.00
惠州市锦同创投资有限责任公司236.914.280.00
华夏银行股份有限公司-广发北交所精选两年定期开放混合型证券投资基金203.353.680.00
中国农业银行股份有限公司-万家北交所慧选两年定期开放混合型证券投资基金178.863.234.42
惠州市锦同盛投资合伙企业(有限合伙)126.122.28-54.54
交通银行股份有限公司-南方北交所精选两年定期开放混合型发起式证券投资基金89.771.6289.77
惠州市锦好医疗科技股份有限公司回购专用证券账户84.461.5384.46
  主力控盘
  公司简介
锦好医疗 所属地域: 广东省 涉及概念: 芯片概念,举牌,融资融券,医疗器械概念
主营业务: 生产、加工、销售电子产品:听觉检查音叉、听力计、耳声发射仪、耳声阻抗测量仪、植入式骨导助听器、人工耳蜗声音处理器、骨桥声音处理器、骨导声音处理器、听觉康复训练仪、耳背式、耳内式、盒式、骨导式助听器;便携式氧气呼吸器、便携式制氧机、医用呼吸道湿化器、医用氧气湿化器、雾化管、雾化吸入管、雾化面罩、医用超声雾化器、压缩式雾化器、医用雾化器、喷雾器、雾化组件;玻璃体温计、体温计、电子体温计、脉搏血氧仪、血压计、血糖仪;电动轮椅车、手动轮椅车、医用拐、肘拐、助行器、站立架电热毯、医用防褥床气垫、胎心仪、吸奶器、拔火罐、干燥剂、理疗仪、脉搏器;货物及技术进出口(依法须经批准的项目,经相关部门批准后方可开展经营活动)。
上市日期: 2021-10-25 每股净资产: 3.80元 每股收益: 0.20元 净利润: 0.19亿元 净利润增长率: -38.54%
营业收入: 1.41亿元 每股现金流: 0.29元 每股公积金: 1.82元 每股未分配利润: 0.97元 总股本: 0.98亿 流通股: 0.55亿
以上信息为合作方、加盟公司及会员收集,本站不拥有版权,版权归原作者所有,所载文章、数据仅供参考,据此操作,风险自负。

中 华 顶 尖 财 经 -- 中 华 顶 尖 网 络 信 息 服 务 中 心